Crinetics Pharmaceuticals (CRNX) Other Non Operating Income (2024 - 2026)
Crinetics Pharmaceuticals' quarterly Other Non Operating Income came in at -$131000.0 in Q1 2026, up 35.47% year-on-year from -$96701.8 in Q1 2025, and down 4.8% quarter-over-quarter from -$125000.0 in Q4 2025.
Crinetics Pharmaceuticals has reported Other Non Operating Income for 3 years, with the latest figure at -$131000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 35.47% year-over-year to -$131000.0; the trailing twelve-month figure through Mar 2026 stood at -$508000.0 (changed N/A YoY), and the FY2025 full-year result was -$357000.0, up 31.21% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$131000.0, down from -$125000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was -$37000.0 in Q3 2024, with the low at -$218000.0 in Q4 2024.
- Average Other Non Operating Income over 3 years is -$127166.7, with a median of -$128000.0 recorded in 2025.
- Peak annual rise in Other Non Operating Income reached 42.66% in 2025, while the deepest fall reached 32.43% in 2025.
- Tracing CRNX's Other Non Operating Income over 3 years: stood at -$218000.0 in 2024, then surged by 42.66% to -$125000.0 in 2025, then retreated by 4.8% to -$131000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$131000.0 (Q1 2026), -$125000.0 (Q4 2025), and -$49000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -131,000.00 |
| Dec 31, 2025 | -125,000.00 |
| Sep 30, 2025 | -49,000.00 |
| Mar 31, 2025 | -203,000.00 |
| Dec 31, 2024 | -218,000.00 |
| Sep 30, 2024 | -37,000.00 |